Companies → MAX HEALTHCARE INSTITUTE LIMITED
Save to list
Remove

MAX HEALTHCARE INSTITUTE LIMITED

India, Haryana, Gurugram
Description
by AI
MAX HEALTHCARE INSTITUTE LIMITED is part of the MAX Group. We are North India's largest provider of comprehensive healthcare services, with a network of 16 hospitals located in Delhi, Gurugram, Faridabad, Meerut, Panchkula, Ludhiana, Allahabad, Kanpur, Phagwara and Dehradun. We provide advanced tertiary, secondary and primary healthcare services across 25 specialities. Our integrated healthcare delivery model seamlessly combines our hospitals, laboratories, day care clinics and home care services. We are the leading provider of cancer care in North India, and had the honour of having the first center to be accredited by the National Accreditation Board for Hospitals & Healthcare Providers (NABH) and the National Accreditation Board for Testing & Calibration Laboratories (NABL) at a single location in the country for providing quality cancer care. We are driven by the objective of enabling healthcare to the common man through cost-effective means. Today, we have the capability of being a complete single source healthcare service provider and one of the few institutions in India providing world-class medical facilities across all major medical disciplines across multiple cities, thereby answering the nation's growing healthcare needs.
Address:

2nd Floor

Capital Cyberscape

Sector-59

Gurugram

Haryana

122011 India

Revenue
Recent news:

How Investors May Respond To Humana (HUM) Balancing Dividends With MaxHealth Deal Amid Margin Pressures

Humana Inc. previously declared a cash dividend of US$0.885 per share, payable on April 24, 2026 to stockholders of record as of March 27, 2026, while also acquiring Florida-based clinic operator MaxHealth to fold into its CenterWell Senior Primary Care network. Together with cautious commentary from Barclays about margin expansion amid rising care costs and tighter Medicare Advantage reimbursement, these moves highlight how Humana is balancing shareholder returns with heavier investment in...

Source: Simply Wall St. Feb 28, 2026

Humana’s MaxHealth Deal Tests Medicare Advantage Strategy And Valuation Gap

Humana, ticker NYSE:HUM, is acquiring MaxHealth to expand its CenterWell Senior Primary Care network. The move targets rising care costs and tighter government reimbursement rates in its Medicare Advantage business. The deal is intended to grow Humana's senior focused primary care footprint through CenterWell Senior Primary Care. For investors watching NYSE:HUM, this deal comes at a time when the stock trades around $190.54 and longer term returns have been weak, including a 28.0% decline...

Source: Simply Wall St. Feb 28, 2026

Barclays Lowers Humana (HUM) Price Target amid Questions on Margin Expansion Outlook

Humana Inc. (NYSE:HUM) is included among the 14 Best GARP Stocks to Buy According to Analysts. On February 25, Barclays lowered its price recommendation on Humana Inc. (NYSE:HUM) to $176 from $245. The firm reiterated an Equal Weight rating on the shares. It said it is “incrementally cautious” about the company’s expectation that Individual Medicare

Source: Insider Monkey Feb 27, 2026

Humana Expands Florida Primary Care As Shares Trade Below Targets

Humana’s CenterWell unit has agreed to acquire MaxHealth to expand its primary care reach in Florida. The deal adds MaxHealth clinics to CenterWell’s network, increasing access to value based care for patients in key Florida markets. The transaction highlights Humana’s (NYSE:HUM) continued focus on primary care delivery and Medicare focused services. For you as an investor following NYSE:HUM, this move sits at the core of Humana’s managed care and senior focused primary care model....

Source: Simply Wall St. Feb 19, 2026

Humana’s CenterWell buys primary care provider MaxHealth

The addition of 82 owned and affiliated clinics in Florida comes as Humana doubles down on its primary care portfolio.

Source: Healthcare Dive Feb 17, 2026

Max Healthcare Institute Ltd (BOM:543220) Q3 2026 Earnings Call Highlights: Strong Revenue ...

Max Healthcare Institute Ltd (BOM:543220) reports a 10% revenue increase, driven by digital and international patient growth, despite facing operational hurdles.

Source: GuruFocus.com Feb 17, 2026

Financial Statistics
Valuation Measures
Current
Quarterly
As of 03/21/2026
Market Cap: 938.83 B
Enterprise Value: 965.85 B
Trailing P/E: 66.40
Forward P/E: 45.59
PEG Ratio (5yr expected): N/A
Price/Sales (ttm): 11.75
Price/Book (mrq): 9.34
Enterprise Value/Revenue: 12.04
Enterprise Value/EBITDA: 43.02
Financial Highlights
Profitability and Income Statement
Profit Margin: 17.43%
Return on Assets (ttm): 7.38%
Return on Equity (ttm): 14.40%
Revenue (ttm): 81.40 B
Net Income Avi to Common (ttm): 14.19 B
Diluted EPS (ttm): 14.57
Balance Sheet and Cash Flow
Total Cash (mrq): 4.97 B
Total Debt/Equity (mrq): 32.58%
Levered Free Cash Flow (ttm): -661.75 M
Company is likely to buy
Company is likely to sell
Disclaimer:

IndexBox is not affiliated with, associated with, or endorsed by this company in any way. The information provided on this page, including company details, is solely for informational purposes. IndexBox makes no representations or warranties about the accuracy or completeness of the information provided.

All data and information is provided “as is” for informational purposes only, and is not intended for trading purposes or financial, investment, tax, legal, accounting or other advice. Please consult your broker or financial representative to verify pricing before executing any trade. IndexBox is not an investment adviser, financial adviser or a securities broker. None of the data and information constitutes investment advice nor an offering, recommendation or solicitation by IndexBox to buy, sell or hold any security or financial product, and IndexBox makes no representation (and has no opinion) regarding the advisability or suitability of any investment.